Refining definitions of severe and advanced heart failure: insight from the swedish heart failure registry to optimize trial design and improve referral to advanced therapies

19 May 2025 (15:00 - 15:45)

Organised by:

Video

Abstract

Slides

Sign in for access options

About the speaker

Doctor Federica Guidetti

Inselspital - University of Bern, Bern (Switzerland)

4 More presentations in this session

Presentation thumbnail

Association between neutrophil-to-lymphocyte ratio, exercise capacity and outcomes in patients with heart failure and reduced ejection fraction

Doctor E. Rodenas Alesina (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Sodium zirconium cyclosilicate for the management of hyperkalaemia in patients with heart failure with reduced ejection fraction - the REALIZE-K open-label run-in phase

Professor M. Petrie (Glasgow, GB)

Abstract Slides Video

Presentation thumbnail

Relative and absolute benefit of dapagliflozin using different eGFR estimates: insights from DAPA-HF trial

Doctor P. Tolomeo (Glasgow, GB)

Abstract Slides Video

Presentation thumbnail

Cardiac rhythm management devices in patients with heart failure - preliminary results of the DIRECT HF international survey on patients' needs and perceptions

Ms R. Monroe (Charlotte, US)

Abstract Slides Video

Access the full session

Session thumbnail

Advances in heart failure therapeutics

The Event

Event poster

Heart Failure 2025

19 May 2025 15:00 CET

You may be interested in

Congress Presentation

The incidence of severe heart failure among hospitalized patients with HFrEF. Do we have a simplified diagnostic criteria helping in the earlier diagnosis and better prognosis?

Congress Session

The changing landscape of heart failure

Congress Session

Advances in heart failure detection and therapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources